Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

U.S. university develops new anticancer products

Aug. 23, 2012

Takeda presents new potent IAP inhibitors with promising oncolytic activity

Aug. 23, 2012

Research collaboration begins for delivery of microRNA-based therapeutics

Aug. 22, 2012

NICE issues new guidance on bevacizumab

Aug. 22, 2012

Novel tyrosine kinase inhibitors patented by Pierre Fabre Medicament

Aug. 22, 2012

New pim-1/2 inhibitors developed

Aug. 22, 2012

Investigation at Sphaera Pharma yields new PI3K/mTOR inhibitors

Aug. 22, 2012

Scientists at Novartis synthesize novel CDK9 inhibitors

Aug. 22, 2012

U.S. university and Novartis launch exclusive licensing agreement

Aug. 21, 2012

Investigational BCR-ABL inhibitor enters new phase I/II trial in Japan

Aug. 21, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...